ROLE OF NEUROMODULATION IN MIGRAINE
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
The RELIEV-CM2 clinical study will investigate the first-ever, head located implantable neuromodulation devicedesigned to treat Chronic Migraine.
We welcome Penney Cowan to the podium for the 8th lecture honoring the foundational contributions of leaders in pain medicine.
#10 in the NIH Pain Consortium Grant-Mechanism Webinar Series The goal of this webinar series is to inform the pain research community of funding opportunities and other resources provided by the […]